Page last updated: 2024-09-04

evodiamine and Mastitis

evodiamine has been researched along with Mastitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Fu, S; Guo, W; Hou, S; Hu, G; Liu, J; Ran, X; Wang, H; Yang, Y; Yang, Z	1

Other Studies

1 other study(ies) available for evodiamine and Mastitis

Article	Year
Evodiamine Relieve LPS-Induced Mastitis by Inhibiting AKT/NF-κB p65 and MAPK Signaling Pathways. Inflammation, 2022, Volume: 45, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Female; Lipopolysaccharides; Mastitis; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Proto-Oncogene Proteins c-akt; Quinazolines; Random Allocation; Signal Transduction; Transcription Factor RelA	2022

Article

Year

Evodiamine Relieve LPS-Induced Mastitis by Inhibiting AKT/NF-κB p65 and MAPK Signaling Pathways.

Inflammation, 2022, Volume: 45, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Female; Lipopolysaccharides; Mastitis; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Proto-Oncogene Proteins c-akt; Quinazolines; Random Allocation; Signal Transduction; Transcription Factor RelA

2022